RAM-Pramipexole - Beligas

Pramipexole exerts its effects by selectively binding to dopamine D2 and D3 receptors in the central nervous system. This stimulation helps to restore the balance of dopamine and can alleviate symptoms of Parkinson’s disease and reduce the frequency and severity of periodic limb movement in sleep disorders.

Indications:
Pramipexole is indicated for the treatment of moderate to advanced idiopathic Parkinson’s disease, either as monotherapy or in combination with other medications. Additionally, it is utilized in the management of primary restless legs syndrome (RLS) to provide symptomatic relief.

Contraindications:
Pramipexole is contraindicated in patients with hypersensitivity to the active ingredient or any of the excipients. It should not be used in individuals with severe renal impairment or in patients with a history of hallucinations or severe mental health disorders unless under close supervision.

Precautions:
Caution is advised in patients with a history of impulse control disorders and those who are elderly, as they may be more susceptible to adverse effects. Additionally, monitoring is essential in patients with renal impairment, as dosage adjustments may be required.

Drug interactions:
Pramipexole may interact with other medications that influence dopaminergic activity, such as other dopamine agonists, antipsychotics, and certain antihypertensive drugs. Co-administration with medications that affect renal function may also alter pramipexole’s levels and efficacy. It is vital for patients to inform their healthcare professional about all medications and supplements they are taking.

Dosage:
The usual starting dose for the treatment of Parkinson’s disease is 0.125 mg taken three times per day, which may be increased gradually based on efficacy and tolerability. For restless legs syndrome, initial dosing may begin at 0.125 mg at bedtime, titrating as necessary. The maximum daily dosage should not exceed the specified limit advised by the prescribing physician.

Storage:
Store in a dark, dry place, at room temperature. Keep out of reach of children.

Regulatory Compliance Statements:
This product complies with relevant regulatory guidelines.
Certified under Good Manufacturing Practices (GMP).

Safety Information:
Overdose Instructions: In case of overdose, seek immediate medical attention.
Adverse Reactions: Report any adverse reactions to your healthcare provider.